SAWAI GROUP HOLDINGS Co., Ltd. Logo

SAWAI GROUP HOLDINGS Co., Ltd.

Pharmaceutical holding company that develops and markets generic and OTC drugs.

4887 | T

Overview

Corporate Details

ISIN(s):
JP3323040000
LEI:
Country:
Japan
Address:
大阪市淀川区宮原5丁目2−30

Description

SAWAI GROUP HOLDINGS Co., Ltd. is a holding company that operates through its subsidiaries in the pharmaceutical field. The group's core activities encompass the research, development, manufacture, and marketing of medical products. It is primarily known for its extensive portfolio of high-quality generic pharmaceuticals, which serve as bioequivalent alternatives to branded drugs across various therapeutic areas, including treatments for hypertension, dyslipidemia, and diabetes. In addition to prescription generics, the company also handles over-the-counter (OTC) and other ethical drugs. The group is committed to enhancing healthcare access and affordability by providing reliable and cost-effective medications to patients and medical professionals.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2023-07-31 09:01
臨時報告書
Japanese ZIP 18.8 KB
2023-06-27 08:07
確認書
Japanese ZIP 9.0 KB
2023-06-27 08:05
内部統制報告書-第2期(2022/04/01-2023/03/31)
Japanese ZIP 23.8 KB
2023-06-27 08:03
有価証券報告書-第2期(2022/04/01-2023/03/31)
Japanese ZIP 1.6 MB
2023-02-13 07:05
確認書
Japanese ZIP 9.0 KB
2023-02-13 07:03
四半期報告書-第2期第3四半期(2022/10/01-2022/12/31)
Japanese ZIP 341.1 KB
2022-11-08 07:01
四半期報告書-第2期第2四半期(令和4年7月1日-令和4年9月30日)
Japanese ZIP 367.7 KB
2022-11-08 07:01
確認書
Japanese ZIP 9.1 KB
2022-08-10 08:00
確認書
Japanese ZIP 9.1 KB
2022-08-10 08:00
四半期報告書-第2期第1四半期(令和4年4月1日-令和4年6月30日)
Japanese ZIP 279.8 KB
2022-06-24 09:09
内部統制報告書-第1期(令和3年4月1日-令和4年3月31日)
Japanese ZIP 24.1 KB
2022-06-24 09:08
確認書
Japanese ZIP 9.1 KB
2022-06-24 09:07
有価証券報告書-第1期(令和3年4月1日-令和4年3月31日)
Japanese ZIP 1.7 MB
2022-02-14 07:02
四半期報告書-第1期第3四半期(令和3年10月1日-令和3年12月31日)
Japanese ZIP 501.8 KB
2021-11-12 07:02
四半期報告書-第1期第2四半期(令和3年7月1日-令和3年9月30日)
Japanese ZIP 518.7 KB

Automate Your Workflow. Get a real-time feed of all SAWAI GROUP HOLDINGS Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SAWAI GROUP HOLDINGS Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SAWAI GROUP HOLDINGS Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.